Anna Kaltenboeck: Untangling Drug Prices

Howie and Harlan are joined by health economist Anna Kaltenboeck, a graduate of Yale SOM’s EMBA program who served as senior health advisor to the Senate Finance Committee during the development of the drug pricing reforms in the Inflation Reduction Act. Harlan reports on recent research on the timing of exercise; Howie reflects on the limitations of a blue-ribbon panel’s recommendations on healthcare spending. Links: Anna Kaltenboeck: “What The Inflation Reduction Act’s Reforms To Medicare Part D Mean For Prescription Drug Prices” “Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study” “For a longer life, afternoon exercise may be best, a large study shows” “Time of day determines postexercise metabolism in mouse adipose tissue” “Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasis” “A Road Map For Action: Recommendations Of The Health Affairs Council On Health Care Spending And Value” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.